Safety and Efficacy of Topically Applied Selected Cutibacterium acnes Strains over Five Weeks in Patients with Acne Vulgaris: An Open-label, Pilot Study
Ante Karoglan, Bernhard Paetzold, Joao Pereira De Lima, Holger Brüggemann, Thomas Tüting, Denny Schanze, Marc Güell, Harald Gollnick
Preview of fully accepted paper, still not published in any volume
Imbalance in skin microflora, particularly related to certain Cutibacterium acnes strains, may trigger acne. Application of non-acne-causing strains to the skin may modulate the skin microbiome and thereby lead to a reduction in acne. This pilot study evaluates the safety and efficacy of microbiome modulation on acne-prone skin. The study had 2 phases: active induction (5% benzoyl peroxide gel, 7 days) and interventional C. acnes strains treatment (5 weeks). Patients were randomized to either topical skin formulations PT1 (2 strains of C. acnes Single Locus Sequence Typing [SLST] type C3 and K8, 50% each) or PT2 (4 strains of C. acnes SLST type C3 [55%], K8 [5%], A5 [30%] and F4 [10%]). Safety and efficacy was evaluated in 14 patients (PT1=8/14, PT2=6/14). Skin microbiome composition shifted towards study formulations. No untoward adverse events, visible irritation, or significant flare-up were observed. Non-inflamed lesions and skin pH were reduced. Comedone counts improved clinically with no deterioration in inflammatory lesions.
This open-label, pilot study enrolled men and women (18–23 years) with acne vulgaris. In 14 enrolled patients, skin microbiome composition shifted towards study formulations. No untoward tolerability, visible irritation, or significant flare-ups were observed. Non-inflamed lesions and skin pH were reduced. Modulation of Cutibacterium acnes towards the non-acne causing strains on the skin of patients with acne was safe. C. acnes was formerly thought to be the cardinal cause of acne; however, recently some, but not all, strains of C. acnes were found to be responsible. This microbiome modulation approach as therapy requires validation in future clinical studies.